1
1
3
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
TP2018L | GIP (human) acetate | GIP (human) acetate(100040-31-1 Free base) | IGF-1R |
GIP (human) acetate is a stimulator of glucose-dependent insulin secretion and a weak inhibitor of gastric acid secretion. GIP (human) acetate plays a vital role in lipid metabolism and the development of obesity. |
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
TN5845 | Neochlorogenic acid methyl ester | 5-O-Caffeoylquinic acid methyl ester,Methyl 3-caffeoylquinate,GIP (1-39) acetate(725474-97-5 Free base),Methyl neochlorogenate | Antioxidant , HBV |
Neochlorogenic acid methyl ester (5-O-Caffeoylquinic acid methyl ester) is derived from Artemisia capillaris and black chokeberry (Aronia melanocarpa) fruits. Neochlorogenic acid methyl ester shows weak anti-HBV activity... |
カタログ番号 | 製品名 | Species | Expression System |
---|---|---|---|
TMPY-00319 | GIP Protein, Human, Recombinant (hFc) | Human | HEK293 |
Glucose-dependent insulinotropic polypeptide (GIP) is an incretin that plays an important role in fat accumulation. GIP is involved in fat accumulation and insulin resistance with aging. Glucose-dependent insulinotropic ... | |||
TMPK-00890 | GIP Protein, Mouse, Recombinant (hFc) | Mouse | HEK293 |
The potential application of glucose-dependent insulinotropic polypeptide (gastric inhibitory polypeptide, GIP) in the management of obesity and type 2 diabetes has been controversial. Initial interest in the therapeutic... | |||
TMPK-00036 | GIP Protein, Human, Recombinant (His) | Human | HEK293 |
The potential application of glucose-dependent insulinotropic polypeptide (gastric inhibitory polypeptide, GIP) in the management of obesity and type 2 diabetes has been controversial. Initial interest in the therapeutic... |